Cancer Diagnostics Market

1. Cancer Diagnostics Market Global Forecast to 2026 Cancer Diagnostics Market is expected to reach USD 26.6 billion by 2026 Growing at a CAGR of 11.5% (2021 – 2026)

2. CANCER DIAGNOSTICS MARKET MARKET OPPORTUNITY OVER NEXT 5 YEARS CAGR of 2021 – 2026 CAGR BY INSTRUMENTS KEY MARKET PLAYERS 26.6b ▪ Danaher Corporation (US) ▪ Becton ▪ Dickinson and Company (US) ▪ Bio-Rad Laboratories, Inc. (US.) ▪ F. Hoffman-La Roche AG (Switzerland) ▪ QIAGEN N.V. (Netherlands) 17.2b ▪Pathology Instruments ▪Imaging Instruments ▪Biopsy 2021 2026 North America Europe Asia Pacific Rest of the World BY APPLICATION ▪Breast Cancer ▪Lung Cancer

3. According to market research report "Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) - Global Forecasts to 2026", published by MarketsandMarkets™, is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 11.5%. Growth of the cancer diagnostics market is driven mainly by increasing incidence of cancer and growth in the number of private diagnostic laboratories. Key Players: Danaher Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US.), F. Hoffman-La Roche AG (Switzerland), QIAGEN N.V. (Netherlands), Fujifilm Corporation (Japan), Aglient Technologies (US) and Thermo Fisher Scientific Inc. (US) etc. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121

4. Browse in-depth TOC on "Cancer Diagnostics Market" 300 - Tables 48 - Figures 280 – Pages Consumables accounted for the larger share of the cancer diagnostics market in 2020 Based on the product, the cancer diagnostics industry is segmented into consumables and instruments. In 2020, the instruments segment accounted for the larger share of the cancer diagnostics market. The large share of this segment can be attributed to the increasing incidence of cancer and increasing number of cancer diagnostics test. By technology, the IVD testing segment accounted for the largest industry share in 2020 Based on the technology, the cancer diagnostics market is segmented into IVD testing, imaging based technique and biopsy technique. The IVD testing segment accounted for the largest market share in 2020. The increasing incidence of cancer and technological advancement are major driving factors for this market. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121

5. Hospitals are the largest end-users of the cancer diagnostics market Based on end-users, the cancer diagnostics market is segmented into hospitals and diagnostic laboratories. The hospitals segment accounted for the largest market share in 2020 due to the rising number of in-house diagnostic procedures performed in hospitals, growing awareness regarding early diagnosis, and the availability of reimbursements. North America dominates the global Lung cancer diagnostics market The cancer diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the cancer diagnostics market. The large share of North America can be attributed to factors such as the increasing incidences of cancer, growing awareness early diagnosis and technological advancement.

6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

7. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com View Full Report - https://www.marketsandmarkets.com/Market-Reports/cancer-diagnostics- market-186559121.html